Pre-submission services
Streamline Your Market Entry with Expert Pre-Submission Support
Streamline Your Market Entry with Expert Pre-Submission Support
We provides complete pre-submission services to help pharmaceutical manufacturers navigate the regulatory landscape and optimize their submissions for regulatory approval, ensuring a successful outcome for pharmaceutical, biologic, medical device, or in-vitro diagnostic products.
Engaging in pre-submission discussions such as FDA and other regulatory bodies is a crucial step in drug’s development, approval, commercialization, and medical device regulation. Pharmaceutical company should utilize this opportunity to present their products and regulatory plans to the FDA and health authorities, seeking their advice on the best course of action.
After reviewing an application, health authorities (HAs) may contact a sponsor or Marketing Authorization Holder (MAH) if the evidence is insufficient or further information is needed regarding efficacy, safety, and quality. This interaction underscores the proactive engagement with regulatory authorities.
Zenovel serves as a global regulatory partner for pharmaceutical companies, managing regulatory agency interactions and health authority meetings for drug development, approval, and post-approval changes. With a robust regulatory team of industry professionals and ex-agency experts, we support sponsors during agency meetings and ensure successful regulatory approval outcomes.
Enhance communication and collaboration between clients and regulatory authorities, promoting transparency, trust, and alignment throughout the submission process.
We help clients ensure your regulatory submissions meet all necessary standards and expectations, reducing the risk of non-compliance.
Tailoring regulatory strategies, navigating regulatory pathways, optimizing resource allocation, and enhancing efficiency of regulatory submission
Clinical trials are crucial for drug development, but managing them is complex due to the vast amount of data and patient safety concerns. Zenovel uses innovative approaches like Risk-Based Monitoring (RBM) to streamline processes, prioritize quality, and enhance trial efficiency. This blog explores RBM’s significance in clinical trials and how
In the dynamic, rapidly changing environment of the pharmaceutical industry, product quality and regulatory compliance is mandated. Computer System Validation (CSV) is essential to that goal, since it demonstrates that computerized systems used in manufacturing, testing or managing data are reliable and compliant. This Zenovel guide gives an overview of
Pharmacokinetics (PK) is a key element of drug development, and describes how a drug interacts with the body by defining its absorption, distribution, metabolism and excretion (ADME). Knowing about PK is essential in drug development to establish the safety and efficacy of drugs (both new and generic). It is Zenovel’s
Over the past few decades, clinical trial monitoring has significantly changed from conventional on-site visits to remote and risk-based monitoring with technology. These developments revolutionized clinical trial conduct, with enhanced efficiency, cost reduction, and increased data quality. At Zenovel, we are leading the charge in excessing these innovations to optimize
The pharmaceutical industry is heavily regulated, and compliance with strict standards is crucial for operational excellence and avoiding penalties. To achieve regulatory readiness, pharmaceutical quality leaders use proactive preparation methods like mock inspections and compliance gap analysis. Zenovel guides companies through these processes to strengthen quality systems, enhance staff readiness,
Quality and compliance are paramount in the life sciences and pharmaceutical industry. Regulatory agencies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the World Health Organization (WHO) have established rigorous requirements that rely on a holistic approach to quality assurance (QA) and validation. At Zenovel,
